Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pustular Psoriasis”

54 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 54 results

Testing effectiveness (Phase 2)Study completedNCT00301002
What this trial is testing

Study to Evaluate the Efficacy of Alefacept to Treat Palmar Plantar Pustulosis

Who this might be right for
PsoriasisPalmoplantaris PustulosisPustular Psoriasis of Palms and Soles+2 more
The Guenther Dermatology Research Centre 15
Post-approval studies (Phase 4)Ended earlyNCT06042920
What this trial is testing

Evaluate Effectiveness and Safety of Deucravacitinib in Participants With Non-Pustular Palmoplantar and Genital Psoriasis

Who this might be right for
Palmoplantar PsoriasisGenital Psoriasis
Bristol-Myers Squibb 130
Testing effectiveness (Phase 2)Study completedNCT03782792
What this trial is testing

Effisayil™ 1: A Study to Test Spesolimab (BI 655130) in Patients With a Flare-up of a Skin Disease Called Generalized Pustular Psoriasis

Who this might be right for
Generalized Pustular Psoriasis
Boehringer Ingelheim 53
Large-scale testing (Phase 3)Study completedNCT05200247
What this trial is testing

An Expanded Access Trial in Japan to Provide Spesolimab to People With a Flare-up in Generalized Pustular Psoriasis Who Have no Other Treatment Options

Who this might be right for
Generalized Pustular Psoriasis
Boehringer Ingelheim 11
Large-scale testing (Phase 3)Study completedNCT03022045
What this trial is testing

Assess Efficacy and Safety of Two Different Dose Regimens of Risankizumab Administered Subcutaneously in Japanese Subjects With Generalized Pustular Psoriasis or Erythrodermic Psoriasis

Who this might be right for
Psoriasis
AbbVie 18
Not applicableStudy completedNCT07428915
What this trial is testing

Evaluating Legit.Health Plus Support for Improving Diagnosis of Generalized Pustular Psoriasis and Other Skin Conditions Among Primary Care Physicians and Dermatologists

Who this might be right for
Pustular Psoriasis (PP)Generalized Pustular Psoriasis (GPP)Eczema Atopic Dermatitis+11 more
AI Labs Group S.L 15
Large-scale testing (Phase 3)Study completedNCT01782937
What this trial is testing

An Open-label, Non-controlled Study of KHK4827 in Subjects With Psoriasis

Who this might be right for
Psoriasis
Kyowa Kirin Co., Ltd. 30
Post-approval studies (Phase 4)Study completedNCT02400749
What this trial is testing

Apremilast in Palmo-Plantar Psoriasis

Who this might be right for
Palmo-plantar Psoriasis
Innovaderm Research Inc. 100
Large-scale testing (Phase 3)UnknownNCT00811005
What this trial is testing

Fumaric Acid Ester-PUVA Therapy Versus Acitretin -PUVA Therapy in Pustular Palmoplantar Psoriasis

Who this might be right for
Pustular Palmoplantar Psoriasis
Medical University of Vienna 20
Large-scale testing (Phase 3)Ended earlyNCT05366855
What this trial is testing

Study to Evaluate the Long-Term Safety and Efficacy of Imsidolimab (ANB019) in the Treatment of Subjects With GPP

Who this might be right for
Generalized Pustular Psoriasis
Vanda Pharmaceuticals 42
Large-scale testing (Phase 3)Study completedNCT05239039
What this trial is testing

An Expanded Access Program in China to Provide Spesolimab to People With a Flare-up in Generalized Pustular Psoriasis Who Have no Other Treatment Options

Who this might be right for
Generalized Pustular Psoriasis
Boehringer Ingelheim 39
Not applicableNot Yet RecruitingNCT07448428
What this trial is testing

Generalized Pustular Psoriasis Registry in Costa Rica

Who this might be right for
Generalized Pustular PsoriasisGeneralized Pustular Psoriasis (GPP)
Caja Costarricense de Seguro Social 50
Not applicableLooking for participantsNCT06100991
What this trial is testing

CorEvitas Generalized Pustular Psoriasis (GPP) Drug Safety and Effectiveness Registry

Who this might be right for
Generalized Pustular Psoriasis
CorEvitas 200
Testing effectiveness (Phase 2)Study completedNCT04399837
What this trial is testing

Test Whether BI 655130 (Spesolimab) Prevents Flare-ups in Patients With Generalized Pustular Psoriasis

Who this might be right for
Generalized Pustular Psoriasis
Boehringer Ingelheim 123
Large-scale testing (Phase 3)Active Not RecruitingNCT06295692
What this trial is testing

JNJ-77242113 for the Treatment of Participants With Generalized Pustular Psoriasis or Erythrodermic Psoriasis

Who this might be right for
Generalized Pustular PsoriasisErythrodermic Psoriasis
Janssen Pharmaceutical K.K. 19
Large-scale testing (Phase 3)Study completedNCT05352893
What this trial is testing

Study to Evaluate the Efficacy and Safety of Imsidolimab (ANB019) in the Treatment of Subjects With GPP

Who this might be right for
Generalized Pustular Psoriasis
Vanda Pharmaceuticals 45
Not applicableUnknownNCT05144165
What this trial is testing

Systemic Treatment of Moderate-to-severe Psoriasis in Adults: Update of the French Guidelines

Who this might be right for
PsoriasisPsoriasis PalmarisPsoriasis Inverse+8 more
Centre of Evidence of the French Society of Dermatology 30
Not applicableStudy completedNCT03885089
What this trial is testing

Infliximab Biosimilar for Intravenous Drip Infusion 100 mg "Pfizer" Drug Use Investigation (Psoriasis)

Who this might be right for
Psoriasis VulgarisPsoriasis ArthropathicaPustular Psoriasis+1 more
Pfizer 10
Large-scale testing (Phase 3)Study completedNCT01952015
What this trial is testing

Study to Assess the Efficacy, Safety and Tolerability of Secukinumab in Japanese Subjects With Generalized Pustular Psoriasis (GPP)

Who this might be right for
Psoriasis
Novartis Pharmaceuticals 12
Not applicableActive Not RecruitingNCT06952465
What this trial is testing

A Study Comparing the Risk of Serious Infections and Malignancies With Deucravacitinib or Biologics in Japanese Patients With Psoriasis

Who this might be right for
Psoriasis
Bristol-Myers Squibb 2,000
Load More Results